Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael Lunski"'
Publikováno v:
Cancer Research. 81:PS6-47
Background: Several reports have observed that cancer patients who recently underwent chemotherapy or surgery had a higher risk of severe events compared with patients without cancer. Limited data is available on outcomes in specific cancer types, as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ead1bff1cfc805eb2ca5aa8688f3e97c
https://doi.org/10.1158/1538-7445.sabcs20-ps6-47
https://doi.org/10.1158/1538-7445.sabcs20-ps6-47
Publikováno v:
Clinical Oncology and Research. :1-6
For decades acute myeloid leukemia, the primary acute leukemia affecting adults, had limited treatment options. Since 2017, we have seen discovery and development in cytogenetic and molecular classification of acute myeloid leukemia, improved underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89a6769a622e45e0404e898a13e8b7e3
https://doi.org/10.31487/j.cor.2021.01.08
https://doi.org/10.31487/j.cor.2021.01.08
Autor:
John T. Cole, Diana Maslov, Victoria Simenson, Karine Tawagi, Helen Yuan, Brian Moore, Marc R. Matrana, Daniel Barr, Jeffrey H. Burton, Daniel H. Johnson, Michael Lunski, Zoe L Larned
Publikováno v:
Cancer
BACKGROUND: This is the largest and only multivariate study evaluating the difference in mortality from coronavirus disease 2019 (COVID-19) between patients with cancer and patients without cancer in the United States. The objective was to assess COV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491a864ac8e1e230d7184fa06b89ab3a
Autor:
Ashley D. Staton, Laura Finn, Ambuga Badari, Michael Lunski, Carter Davis, Muhammad Azeem Khan
Publikováno v:
Integrative Molecular Medicine. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8de4392ad22aa27ec14dd5faefac1623
https://doi.org/10.15761/imm.1000405
https://doi.org/10.15761/imm.1000405
Publikováno v:
Clinical Cancer Research. 26:PO-081
Introduction: While many data have been emerging regarding the outcomes of cancer patients infected with SARS-CoV-2 and their increased risk of mortality, emphasis on patients with hematologic malignancies and how they have been affected during this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2db95586d2cc0fd20f9b4715a3f1d27d
https://doi.org/10.1158/1557-3265.covid-19-po-081
https://doi.org/10.1158/1557-3265.covid-19-po-081
Autor:
Michael Lunski, Karine Tawagi, Marc Matrana, Daniel H. Johnson, Diana Maslov, Jeffrey H. Burton
Publikováno v:
Clinical Cancer Research. 26:PO-083
Background: Early reports on cancer patients infected with COVID-19 have suggested a high risk of hospitalization and death compared to the general population. Limited data are available on outcomes in specific cancer types. We aim to identify whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4196023406f8dedbd980add8ffdcef
https://doi.org/10.1158/1557-3265.covid-19-po-083
https://doi.org/10.1158/1557-3265.covid-19-po-083
Autor:
Jennifer Vaughn, Zhi Sheng, Michael Lunski, James W. Smyth, Benjamin Purow, Robert G. Gourdie, Samy Lamouille
Publikováno v:
Cancer Research. 79:4284-4284
Glioblastoma (GBM) is a highly malignant and lethal cancer of the central nervous system for which there has been limited progress in improving patient outcomes despite intensive research efforts. The current multimodal therapy for newly diagnosed GB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d358ccdb297ef7ee3a49c2fe94bd20c7
https://doi.org/10.1158/1538-7445.am2019-4284
https://doi.org/10.1158/1538-7445.am2019-4284